AR060205A1 - Composicion farmaceutica sinergistica de carisoprodol y clonixinato de lisina - Google Patents

Composicion farmaceutica sinergistica de carisoprodol y clonixinato de lisina

Info

Publication number
AR060205A1
AR060205A1 ARP070104561A ARP070104561A AR060205A1 AR 060205 A1 AR060205 A1 AR 060205A1 AR P070104561 A ARP070104561 A AR P070104561A AR P070104561 A ARP070104561 A AR P070104561A AR 060205 A1 AR060205 A1 AR 060205A1
Authority
AR
Argentina
Prior art keywords
carisoprodol
clonixinate
lisine
pharmaceutical composition
synergistic pharmaceutical
Prior art date
Application number
ARP070104561A
Other languages
English (en)
Inventor
Sanchez Carmen Miguel Gomez
Suarez Graciela De Lo Aguilera
Lora Martha Rosaura Juarez
Original Assignee
Farmaceuticos Rayere S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceuticos Rayere S A filed Critical Farmaceuticos Rayere S A
Publication of AR060205A1 publication Critical patent/AR060205A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones farmacéuticas que contienen un relajante muscular conocido como carisoprodol y el otro un analgésico anti-inflamatorio no esteroideo conocido como clonixinato de lisina. Cuando se combinan ambos fármacos en proporciones específicas la combinacion produce efectos farmacologicos que indican una sinergia, por lo que es posible usar menos cantidad de ambos fármacos para lograr el mismo grado de analgesia y relajamiento muscular que cuando se usan solos, con la ventaja de tener menos efectos adversos.
ARP070104561A 2006-10-30 2007-10-12 Composicion farmaceutica sinergistica de carisoprodol y clonixinato de lisina AR060205A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2006/000118 WO2008054188A1 (es) 2006-10-30 2006-10-30 Composición farmacéutica sinergística de carisoprodol y clonixinato de lisina

Publications (1)

Publication Number Publication Date
AR060205A1 true AR060205A1 (es) 2008-06-04

Family

ID=39344480

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104561A AR060205A1 (es) 2006-10-30 2007-10-12 Composicion farmaceutica sinergistica de carisoprodol y clonixinato de lisina

Country Status (4)

Country Link
AR (1) AR060205A1 (es)
CL (1) CL2007003136A1 (es)
MX (1) MX2007012517A (es)
WO (1) WO2008054188A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1103205A2 (pt) * 2011-06-03 2014-02-25 Eurofarma Lab Ltda Composição farmacêutica oral e uso da composição farmacêutica oral

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205492A1 (en) * 1984-12-26 1986-12-30 SUNSHINE, Abraham Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic

Also Published As

Publication number Publication date
CL2007003136A1 (es) 2008-02-15
WO2008054188A1 (es) 2008-05-08
MX2007012517A (es) 2009-02-26

Similar Documents

Publication Publication Date Title
MX2009004203A (es) Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
CL2008001268A1 (es) Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor.
UA87841C2 (ru) Композиция, которая содержит амброксол, для местного применения
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
CL2008003901A1 (es) Uso de un inhibidor de hedgehog para extender la sobrevida libre de recidiva en un paciente con cancer, que se encuentra en quimioterapia o ha sido tratado previamente con quimioterapia.
EA201100958A1 (ru) Фармацевтическая пероральная дозированная лекарственная форма на основе ингибиторов dpp iv
PE20081114A1 (es) Composiciones farmaceuticas bioadhesivas de agente dual para uso topico
CL2008000610A1 (es) Composicion en forma de dosificacion transdermica o transmucosa que comprende una relacion en peso de buprenorfina a naloxona entre 2,1:1 y 8:1, util para el tratamiento del dolor.
BRPI0508680A (pt) composição de resfriamento natural, composição flavorizante, produto pronto-para-consumo, e, uso de uma composição
BRPI0816798A2 (pt) composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
UY28517A1 (es) Nueva combinación
BRPI0513938B8 (pt) composição farmacêutica contendo drospirenona e etinilestradiol
EA200901237A1 (ru) Применение димирацетама при лечении хронической боли
AR052830A1 (es) Regimen de cladribina para tratar esclerosis multiple
AR030957A1 (es) Composiciones de analgesico y glucosamina
PE20090625A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
BRPI0810773A2 (pt) Composição farmacêutica, métodos para tratar dor em um mamífero, para tratar depressão em um mamífero, para tratar um distúrbio em um paciente, para fabricar um composto, e para inibir a captação de norepinefrina, composto, e, uso de uma composição.
CL2008001477A1 (es) Composicion farmaceutica compuesta por la combinacion sinergica de un agente anticonvulsivante como gabapentina y un agente antiinflamatorio no esteroideo como meloxicam, los rangos de concentracion presentes para la gabapentina son 3 a 300 mg y de 0,1 a 30 mg para meloxicam; y uso para tratar el dolor neuropatico
AR060205A1 (es) Composicion farmaceutica sinergistica de carisoprodol y clonixinato de lisina
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
CO6331430A2 (es) Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia
AR044831A1 (es) Forma de administracion inyectable de la flupirtina
ECSP066836A (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
AR055807A1 (es) Composicion farmaceutica sinergistica de diclofenaco y clonixinato de lisina
BRPI0604461A (pt) composição farmaceutica estavel de carisoprodol e meloxicam

Legal Events

Date Code Title Description
FB Suspension of granting procedure